Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer
- 1 June 2004
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 5 (6), 597-605
- https://doi.org/10.1016/j.ccr.2004.05.016
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cellsOncogene, 2002
- Stable suppression of tumorigenicity by virus-mediated RNA interferenceCancer Cell, 2002
- Fulvestrant, Formerly ICI 182,780, Is as Effective as Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing After Prior Endocrine TreatmentJournal of Clinical Oncology, 2002
- Endocrine-responsive breast cancer and strategies for combating resistanceNature Reviews Cancer, 2002
- Functional Discovery via a Compendium of Expression ProfilesCell, 2000
- Phosphorylation of Human Estrogen Receptor α by Protein Kinase A Regulates DimerizationMolecular and Cellular Biology, 1999
- Estrogen Receptor VariantsJournal of Mammary Gland Biology and Neoplasia, 1998
- Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein KinaseScience, 1995
- Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancerThe Lancet, 1995
- CLINICAL SIGNIFICANCE OF TAMOXIFEN WITHDRAWAL RESPONSEThe Lancet, 1987